[Clinically mild encephalitis/encephalopathy with a reversible splenial lesion of corpus callosum in a child and literature review]
- PMID: 24824394
[Clinically mild encephalitis/encephalopathy with a reversible splenial lesion of corpus callosum in a child and literature review]
Abstract
Objective: To investigate the characteristics of a new clinical-image syndrome-mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) of corpus callosum.
Method: The clinical and imaging features of one pediatric patient with the diagnosis of MERS were analyzed and the clinical and radiologic data of 44 MERS cases which were reported all around the world were also analyzed.
Result: The underlying disease of the patient before the onset was respiratory mycoplasma infection. On the second day of the disease course, the patient presented symptoms of encephalopathy. Brain MRI indicated lesions in the splenium of corpus callosum, centrum semiovate and posterior periventricular white matter. And these lesions recovered completely within 3 weeks. Most of the 44 patients diagnosed with MERS were associated with infectious diseases and completely recovered within two weeks. Symptoms included consciousness disturbance, convulsions and dysarthria. In addition to the splenium, brain MRI also showed lesions in genu of corpus callosum, centrum semiovate and white matter of frontal lobe.
Conclusion: The clinical presentations of MERS were sudden onset of symptoms of encephalopathy during acute inflammation. Brain MRI indicated a reversible lesion in the splenium of corpus callosum. Patients recover completely within a few days.
Similar articles
-
Differences in the time course of splenial and white matter lesions in clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS).J Neurol Sci. 2010 May 15;292(1-2):24-7. doi: 10.1016/j.jns.2010.02.013. Epub 2010 Mar 16. J Neurol Sci. 2010. PMID: 20236662
-
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion of corpus callosum in Chinese children.Brain Dev. 2017 Apr;39(4):321-326. doi: 10.1016/j.braindev.2016.10.009. Epub 2016 Nov 4. Brain Dev. 2017. PMID: 27823946
-
Clinically mild encephalitis with a reversible splenial lesion (MERS) after mumps vaccination.J Neurol Sci. 2015 Feb 15;349(1-2):226-8. doi: 10.1016/j.jns.2014.12.019. Epub 2014 Dec 18. J Neurol Sci. 2015. PMID: 25542078
-
Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review.BMC Neurol. 2017 May 25;17(1):103. doi: 10.1186/s12883-017-0875-5. BMC Neurol. 2017. PMID: 28545419 Free PMC article. Review.
-
Mild Encephalitis/Encephalopathy with Reversible Splenial Lesion (MERS) due to Cytomegalovirus: Case Report and Review of the Literature.Neuropediatrics. 2018 Feb;49(1):68-71. doi: 10.1055/s-0037-1608779. Epub 2017 Nov 27. Neuropediatrics. 2018. PMID: 29179234 Review.
Cited by
-
Reversible splenial lesion syndrome in children: clinical analysis and summary of a case series.J Int Med Res. 2020 Apr;48(4):300060520914202. doi: 10.1177/0300060520914202. J Int Med Res. 2020. PMID: 32249648 Free PMC article.
-
Cytotoxic lesion of the corpus callosum in pediatrics: A case report.Radiol Case Rep. 2023 Apr 11;18(6):2186-2193. doi: 10.1016/j.radcr.2023.02.053. eCollection 2023 Jun. Radiol Case Rep. 2023. PMID: 37101890 Free PMC article.
-
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with Mycoplasma pneumoniae infection.BMC Infect Dis. 2016 May 26;16:230. doi: 10.1186/s12879-016-1556-5. BMC Infect Dis. 2016. PMID: 27230114 Free PMC article.
-
Mild encephalopathy/encephalitis with a reversible splenial lesion (MERS): A report of five neonatal cases.J Huazhong Univ Sci Technolog Med Sci. 2017 Jun;37(3):433-438. doi: 10.1007/s11596-017-1753-5. Epub 2017 Jun 6. J Huazhong Univ Sci Technolog Med Sci. 2017. PMID: 28585150
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
